Results 21 to 30 of about 57,303 (248)
Human Vaccines & Immunotherapeutics, 2021 Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population.
Daniela Marín-Hernández +2 more
doaj +1 more source
Safety of BCG vaccination and revaccination in healthcare workers
Human Vaccines & Immunotherapeutics, 2023 BCG vaccination and revaccination are increasingly being considered for the protection of adolescents and adults against tuberculosis and, more broadly, for the off-target protective immunological effects against other infectious and noninfectious ...
Paola Villanueva +16 more
doaj +1 more source
Tuberculosis control by novel vaccines development and Indian initiatives
MGM Journal of Medical Sciences, 2023 Pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the worst microbial diseases of humankind and an awful societal problem, especially in underdeveloped countries.
Prasanta Kumar Ghosh
doaj +1 more source
Angewandte Chemie, EarlyView.We present an integrated workflow that predicts activity‐enhancing mutation combinations from minimal experimental data. By proposing in vivo unit yield (yield/expression) as a surrogate for kcat/Km through causal inference, and visualizing local activity landscape, it effectively guides product yield improvement. ABSTRACT Designing enzyme sequences to
Lin Guo +15 more
wiley +2 more sources
Effectiveness of booster BCG vaccination in preventing Covid-19 infection
Human Vaccines & Immunotherapeutics, 2021 The evidence that BCG (bacille Calmette-Guerin) vaccine may increase the ability of the immune system to fight off pathogens other than tuberculosis has been studied in the past.
lradj Amirlak +5 more
doaj +1 more source
Société Internationale d’Urologie Journal, 2022 There is a critical need to establish reference response rates following bladder-sparing therapies administered in the setting of bacillus Calmete-Guerin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC).
Kyle M. Rose +10 more
doaj +1 more source
OncoImmunology, 2019 Background: Intravesical bacillus Calmette-Guérin (BCG) is the gold standard immunologic agent for treating patients with high-grade non-muscle invasive bladder cancer (NMIBC).
Niannian Ji +12 more
doaj +1 more source
Archives of Medical Science, 2023 Introduction After 3 years of the pandemic, predictors of COVID-19 severity in children are still not completely known. This study was designed to define the high-risk group in hospitalized children.
Lidia Stopyra +3 more
doaj +1 more source
BCG Aortitis, a Rare Complication of BCG Therapy
EJVES Vascular Forum, 2023 Intravesical Bacillus Calmette-Guerin (BCG) is an effective treatment for in situ bladder carcinomas; however, extravesical BCG infection may occur in remote organs in patients with underlying primary immunodeficiency and is a potentially serious complication in 3-5% of cases.
Joseph Haddad +4 more
openaire +3 more sources
The role of BCG in prevention of tuberculosis and the strategies to improve its immunogenicity
Health Promotion & Physical Activity, 2018 Tuberculosis (TB) remains a major public health problem and the main cause of death from the infectious diseases worldwide. Mycobacterium tuberculosis (Mtb), a causative agent of tuberculosis, is the oldest known human pathogen.
Jolanta Mazurek
doaj +1 more source